The Translational Genomics Research Institute
Fungus responsible for five deaths in the wake of massive tornado
A fast growing, flesh-eating fungus killed 5 people following a massive tornado that devastated Joplin, Mo., according to two new studies based on genomic sequencing by the Translational Genomics Research Institute (TGen) ...
Diseases, Conditions, Syndromes
Dec 14, 2012 |
5 / 5 (3) |
0
|
First WGS of multiple pancreatic cancer patients outlined in new study
Whole genome sequencing—spelling out all 3 billion letters in the human genome—"is an obvious and powerful method for advancing our understanding of pancreatic cancer," according to a new study from TGen, Mayo Clinic ...
Cancer
Oct 10, 2012 |
not rated yet |
0
|
Whole genome sequencing of rare olfactory neuroblastoma
The Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare have conducted whole genome sequencing (WGS) of a rare nasal tract cancer called olfactory neuroblastoma ...
Genetics
May 23, 2012 |
not rated yet |
0
|
Clinical trial finds new class of cancer drugs safe and effective
The safety and preliminary efficacy of a new class of tumor fighting drugs were reported today by Scottsdale Healthcare's Virginia G. Piper Cancer Center Clinical Trials and the Translational Genomics Research Institute (TGen).
Cancer
Apr 09, 2013 |
5 / 5 (2) |
0
First study of clonal evolution in Maxillary Sinus Carcinoma
Knowing how tumors evolve can lead to new treatments that could help prevent cancer from recurring, according to a study published today by the Translational Genomics Research Institute (TGen) and Scottsdale Healthcare.
Cancer
Sep 28, 2012 |
not rated yet |
0
New trial drug a 'Trojan Horse' attacking pancreatic cancer
An investigational drug that acts like a Trojan Horse to deliver cancer killing agents for pancreatic cancer is being studied at the Virginia G. Piper Cancer Center Clinical Trials, a partnership between Scottsdale Healthcare ...
Cancer
Jun 14, 2012 |
not rated yet |
0
Clinical trial results for BIND-014 presented at AACR 2013
The nanoparticle drug BIND-014 is effective against multiple solid tumors, according to results generated by the Translational Genomics Research Institute (TGen) and Scottsdale Healthcare, and presented today at the American ...
Cancer
Apr 09, 2013 |
not rated yet |
0
TGen professor discusses benefits of whole genome sequencing in study of multiple myeloma
The scientific benefits of whole genome sequencing at the Translational Genomics Research Institute (TGen) will be presented at the 14th International Myeloma Workshop, April 3-7 at the Kyoto International Conference Center.
Cancer
Apr 03, 2013 |
not rated yet |
0
Researchers help test cancer drug in clinical trial leading to FDA approval
The FDA has approved a thyroid cancer drug successfully tested at Virginia G. Piper Cancer Center Clinical Trials, a partnership of Scottsdale Healthcare and the Translational Genomics Research Institute (TGen).
Cancer
Mar 27, 2013 |
not rated yet |
0
'Plant Purple-Grow Hope' campaign digs in for third season
More northwest Ohio garden centers this spring are teaming up with an Arizona-based biomedical research organization to fight pancreatic cancer through the sale of purple flowers, which symbolize the nation's fourth leading ...
Cancer
Mar 19, 2013 |
not rated yet |
0
Study shows drug combination extends pancreatic cancer patient survival
A multi-center Phase III clinical trial demonstrates that Abraxane (nab-paclitaxel) plus gemcitabine is the first combination of cancer drugs to extend survival of late-stage pancreatic cancer patients compared to standard ...
Cancer
Jan 22, 2013 |
5 / 5 (1) |
0
TGen-US Oncology data guides treatment of metastatic triple-negative breast cancer patients
Genomic sequencing has revealed therapeutic drug targets for difficult-to-treat, metastatic triple-negative breast cancer (TNBC), according to an unprecedented study by the Translational Genomic Research Institute (TGen) ...
Cancer
Dec 06, 2012 |
5 / 5 (1) |
0
Phase III worldwide study of new drug for patients with pancreatic cancer
A new cancer drug combination demonstrated significant improvement in overall survival of late-stage pancreatic cancer patients compared to those receiving standard treatment, according to results of a Phase III clinical ...
Cancer
Nov 19, 2012 |
not rated yet |
0
Study targets non-small cell lung cancer
A Phase I/II, multi-center trial designed to test the safety and preliminary efficacy of a first in class cancer treatment opened worldwide today at the Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, ...
Cancer
Aug 29, 2012 |
5 / 5 (1) |
0
TGen method isolates biospecimens for treatment of kidney disease
Researchers at the Translational Genomics Research Institute (TGen) have developed a method of isolating biospecimens that could lead to a less costly, less invasive and more accurate way of diagnosing chronic kidney disease, ...
Diseases, Conditions, Syndromes
Jul 11, 2012 |
not rated yet |
0
